与此同时,该公司在周二收盘后表示,Idera 不再招募患者进入 tilsotolimod 与 BMS的 Yervoy 和 ...查看全文
$井寺制药(IDRA)$ 内部交易: 2016-10-03,Director,ZEIN YOUSSEF EL ,买入,4228普通股, $2.56
$井寺制药(IDRA)$ 8-K - Current report Filed: 2016-10-05 AccNo: 0001104659-16-148940 Size: 334 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$井寺制药(IDRA)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-10-05 AccNo: 0001047469-16-015966 Size: 574 KB 网页链接
$井寺制药(IDRA)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-02 AccNo: 0001193125-16-667395 Size: 2 MB 网页链接
$井寺制药(IDRA)$ 8-K - Current report Filed: 2016-06-17 AccNo: 0001104659-16-127941 Size: 41 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$井寺制药(IDRA)$ 美东时间 2016-06-21 14:00 Idera Pharmaceuticals Inc at JMP Securities Life Sciences Conference 网页链接
$井寺制药(IDRA)$ 美东时间 2016-06-09 16:00 Idera Pharmaceuticals Inc at Jefferies Healthcare Conference 网页链接
$井寺制药(IDRA)$ 美东时间 2016-06-09 16:00 Idera Pharmaceuticals Inc at Jefferies Healthcare Conference 网页链接
$井寺制药(IDRA)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-03-23 AccNo: 0000000000-16-069389 Size: 158 KB 网页链接
$井寺制药(IDRA)$ CORRESP [Cover] - Correspondence Filed: 2016-04-25 AccNo: 0001104659-16-113795 Size: 11 KB 网页链接